BACKGROUND: In the host defence of the lung neutrophils (PMN) play a central role. Apart from antimicrobial properties, recent data indicate that PMN also exert anti-inflammatory effects by stimulation and release of cytokine antagonists such as interleukin-1 receptor antagonist (IL-1ra). METHODS: Cytokine release from lipopolysaccharide stimulated whole blood was studied in 18 patients with community acquired pneumonia (CAP) and severe co-morbidities at admission and after 24 hours. Release of IL-1ra, interleukin-1beta (IL-1beta), tumour necrosis factor alpha (TNFalpha), soluble TNF receptor type I (sTNF-RI), and IL-8 was determined by ELISA. RESULTS: The mean (SD) leucocyte level at admission was 12.5 (4.1)/nl. There was a significant correlation between the release of anti-inflammatory cytokines such as IL-1ra and sTNF-RI and the leucocyte count at admission and after 24 hours. Additional in vitro experiments showed that co-incubation of peripheral blood mononuclear cells with autologous PMN led to a marked dose dependent increase in IL-1ra and sTNF-RI release. CONCLUSION: These results indicate that PMN may be responsible for the increase in anti-inflammatory cytokines in CAP. Strategies to increase neutrophil counts may exert beneficial effects, not only by augmenting the antimicrobial activity but also by modulating the inflammatory cytokine response.
BACKGROUND: In the host defence of the lung neutrophils (PMN) play a central role. Apart from antimicrobial properties, recent data indicate that PMN also exert anti-inflammatory effects by stimulation and release of cytokine antagonists such as interleukin-1 receptor antagonist (IL-1ra). METHODS: Cytokine release from lipopolysaccharide stimulated whole blood was studied in 18 patients with community acquired pneumonia (CAP) and severe co-morbidities at admission and after 24 hours. Release of IL-1ra, interleukin-1beta (IL-1beta), tumour necrosis factor alpha (TNFalpha), soluble TNF receptor type I (sTNF-RI), and IL-8 was determined by ELISA. RESULTS: The mean (SD) leucocyte level at admission was 12.5 (4.1)/nl. There was a significant correlation between the release of anti-inflammatory cytokines such as IL-1ra and sTNF-RI and the leucocyte count at admission and after 24 hours. Additional in vitro experiments showed that co-incubation of peripheral blood mononuclear cells with autologous PMN led to a marked dose dependent increase in IL-1ra and sTNF-RI release. CONCLUSION: These results indicate that PMN may be responsible for the increase in anti-inflammatory cytokines in CAP. Strategies to increase neutrophil counts may exert beneficial effects, not only by augmenting the antimicrobial activity but also by modulating the inflammatory cytokine response.
Authors: Anja K Schröder; Maren von der Ohe; Ute Kolling; Julia Altstaedt; Peter Uciechowski; Daniela Fleischer; Klaus Dalhoff; Xinsheng Ju; Martin Zenke; Nicole Heussen; Lothar Rink Journal: Immunology Date: 2006-11 Impact factor: 7.397
Authors: R Menéndez; A Torres; R Zalacaín; J Aspa; J J Martín Villasclaras; L Borderías; J M Benítez Moya; J Ruiz-Manzano; F Rodríguez de Castro; J Blanquer; D Pérez; C Puzo; F Sánchez Gascón; J Gallardo; C Alvarez; L Molinos Journal: Thorax Date: 2004-11 Impact factor: 9.139
Authors: William W Siljan; Jan C Holter; Ståle H Nymo; Einar Husebye; Thor Ueland; Pål Aukrust; Tom E Mollnes; Lars Heggelund Journal: Eur J Clin Invest Date: 2017-12-07 Impact factor: 4.686
Authors: Ali Danesh; Cheryl M Cameron; Alberto J León; Longsi Ran; Luoling Xu; Yuan Fang; Alyson A Kelvin; Thomas Rowe; Honglin Chen; Yi Guan; Colleen B Jonsson; Mark J Cameron; David J Kelvin Journal: Virology Date: 2010-10-28 Impact factor: 3.616
Authors: Rafael Fernandez-Botran; Silvia M Uriarte; Forest W Arnold; Lisandra Rodriguez-Hernandez; Madhavi J Rane; Paula Peyrani; Timothy Wiemken; Robert Kelley; Srinivas Uppatla; Rodrigo Cavallazzi; Francesco Blasi; Letizia Morlacchi; Stefano Aliberti; Colleen Jonsson; Julio A Ramirez; Jose Bordon Journal: Inflammation Date: 2014-08 Impact factor: 4.092